No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Adipocytokine signaling pathway 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
2 | Adrenergic signaling in cardiomyocytes 14 genes, 6 drugs (DrugBank) and 21 diseases shown |
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
1件: ADRB1 |
D00601 |
Metoprolol |
7件: 17, 57, 58, 66, 113, 193, 226 |
D02358 |
D05011 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
1件: SCN5A |
D01450 |
Bupivacaine |
7件: 46, 53, 70, 96, 168, 226, 298 |
D07552 |
D00358 |
Lidocaine |
10件: 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
D02086 |
D08127 |
3 | African trypanosomiasis 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
4 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
5 | Aldosterone synthesis and secretion 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
6 | Allograft rejection 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
7 | Alzheimer disease 10 genes, 5 drugs (DrugBank) and 59 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
8 | Amoebiasis 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
9 | Amphetamine addiction 7 genes, 3 drugs (DrugBank) and 55 diseases shown |
2件: CACNA1C, CACNA1D |
D08441 |
Propiverine |
1件: 226 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
10 | AMPK signaling pathway 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ADRA1A |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
11 | Amyotrophic lateral sclerosis (ALS) 6 genes, 4 drugs (DrugBank) and 59 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
12 | Antifolate resistance 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
13 | Antigen processing and presentation 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
14 | Apoptosis 2 genes, 3 drugs (DrugBank) and 16 diseases shown |
1件: NGF |
D09387 |
Tanezumab |
2件: 226, 298 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
15 | Arachidonic acid metabolism 2 genes, 1 drug (DrugBank) and 2 diseases shown |
2件: PTGS1, PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 8 genes, 2 drugs (DrugBank) and 7 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
17 | Asthma 2 genes, 3 drugs (DrugBank) and 20 diseases shown |
1件: FCER1A |
D05251 |
Omalizumab |
6件: 53, 65, 98, 162, 226, 299 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
18 | Axon guidance 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
19 | B cell receptor signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
20 | Breast cancer 2 genes, 1 drug (DrugBank) and 5 diseases shown |
2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
21 | C-type lectin receptor signaling pathway 7 genes, 5 drugs (DrugBank) and 60 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
22 | Calcium signaling pathway 21 genes, 8 drugs (DrugBank) and 64 diseases shown |
6件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
1件: ADRB1 |
D00601 |
Metoprolol |
7件: 17, 57, 58, 66, 113, 193, 226 |
D02358 |
D05011 |
1件: ADRB3 |
D09535 |
Mirabegron |
3件: 6, 13, 226 |
8件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM5 |
D08441 |
Propiverine |
1件: 226 |
1件: OXTR |
D00089 |
Oxytocin |
4件: 127, 193, 206, 226 |
1件: P2RX3 |
D11349 |
Gefapixant |
2件: 85, 226 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
23 | cAMP signaling pathway 9 genes, 4 drugs (DrugBank) and 17 diseases shown |
1件: ADRB1 |
D00601 |
Metoprolol |
7件: 17, 57, 58, 66, 113, 193, 226 |
D02358 |
D05011 |
2件: ADRB1, ADRB2 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
6件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2 |
D08441 |
Propiverine |
1件: 226 |
1件: OXTR |
D00089 |
Oxytocin |
4件: 127, 193, 206, 226 |
24 | Carbohydrate digestion and absorption 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CACNA1D |
D08441 |
Propiverine |
1件: 226 |
25 | Cardiac muscle contraction 8 genes, 2 drugs (DrugBank) and 7 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
26 | Cellular senescence 6 genes, 3 drugs (DrugBank) and 55 diseases shown |
1件: CACNA1D |
D08441 |
Propiverine |
1件: 226 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
27 | cGMP-PKG signaling pathway 20 genes, 10 drugs (DrugBank) and 75 diseases shown |
9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
3件: ADRA2A, ADRA2B, ADRA2C |
D00514 |
Dexmedetomidine |
11件: 2, 4, 6, 21, 34, 70, 113, 212, 215, 226, 280 |
D01205 |
1件: ADRB1 |
D00601 |
Metoprolol |
7件: 17, 57, 58, 66, 113, 193, 226 |
D02358 |
D05011 |
1件: ADRB3 |
D09535 |
Mirabegron |
3件: 6, 13, 226 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
1件: OPRD1 |
D01340 |
Naloxone |
2件: 6, 226 |
D08249 |
D03783 |
Oxycodone |
7件: 6, 13, 46, 70, 226, 231, 298 |
D05312 |
D05462 |
1件: PDE5A |
D02229 |
Sildenafil |
16件: 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
D08514 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
28 | Chagas disease (American trypanosomiasis) 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
29 | Chemical carcinogenesis 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
30 | Cholinergic synapse 9 genes, 1 drug (DrugBank) and 1 disease shown |
9件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D08441 |
Propiverine |
1件: 226 |
31 | Circadian entrainment 2 genes, 1 drug (DrugBank) and 1 disease shown |
2件: CACNA1C, CACNA1D |
D08441 |
Propiverine |
1件: 226 |
32 | Complement and coagulation cascades 1 gene, 1 drug (DrugBank) and 11 diseases shown |
1件: SERPINC1 |
D07510 |
Heparin |
11件: 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317 |
33 | Cortisol synthesis and secretion 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
34 | Cushing syndrome 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
35 | Cytokine-cytokine receptor interaction 2 genes, 3 drugs (DrugBank) and 16 diseases shown |
1件: NGF |
D09387 |
Tanezumab |
2件: 226, 298 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
36 | Dilated cardiomyopathy (DCM) 10 genes, 6 drugs (DrugBank) and 29 diseases shown |
1件: ADRB1 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
D00601 |
Metoprolol |
7件: 17, 57, 58, 66, 113, 193, 226 |
D02358 |
D05011 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
37 | Dopaminergic synapse 6 genes, 5 drugs (DrugBank) and 62 diseases shown |
2件: CACNA1C, CACNA1D |
D08441 |
Propiverine |
1件: 226 |
3件: PPP3CA, PPP3CB, PPP3CC |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SCN1A |
D01450 |
Bupivacaine |
7件: 46, 53, 70, 96, 168, 226, 298 |
D07552 |
D00358 |
Lidocaine |
10件: 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
D02086 |
D08127 |
38 | Drug metabolism - other enzymes 2 genes, 2 drugs (DrugBank) and 34 diseases shown |
2件: IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
39 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: ESR1 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
40 | Endocrine resistance 2 genes, 1 drug (DrugBank) and 5 diseases shown |
2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
41 | Epstein-Barr virus infection 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
42 | Estrogen signaling pathway 3 genes, 4 drugs (DrugBank) and 11 diseases shown |
2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
1件: OPRM1 |
D01340 |
Naloxone |
2件: 6, 226 |
D08249 |
D03783 |
Oxycodone |
7件: 6, 13, 46, 70, 226, 231, 298 |
D05312 |
D05462 |
D01355 |
Tramadol |
5件: 46, 70, 78, 226, 271 |
D08623 |
43 | Fc epsilon RI signaling pathway 2 genes, 3 drugs (DrugBank) and 20 diseases shown |
1件: FCER1A |
D05251 |
Omalizumab |
6件: 53, 65, 98, 162, 226, 299 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
44 | Fluid shear stress and atherosclerosis 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
45 | GABAergic synapse 5 genes, 2 drugs (DrugBank) and 7 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
1件: SLC6A1 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
46 | Gap junction 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: ADRB1 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
D00601 |
Metoprolol |
7件: 17, 57, 58, 66, 113, 193, 226 |
D02358 |
D05011 |
47 | Gastric acid secretion 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CHRM3 |
D08441 |
Propiverine |
1件: 226 |
48 | Glucagon signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
49 | Glutamatergic synapse 7 genes, 3 drugs (DrugBank) and 55 diseases shown |
2件: CACNA1C, CACNA1D |
D08441 |
Propiverine |
1件: 226 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
50 | GnRH secretion 5 genes, 2 drugs (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
1件: ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
51 | GnRH signaling pathway 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
52 | Graft-versus-host disease 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
53 | Growth hormone synthesis, secretion and action 4 genes, 1 drug (DrugBank) and 1 disease shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
54 | Hematopoietic cell lineage 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
55 | Hepatitis B 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
56 | Hepatitis C 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
57 | Herpes simplex virus 1 infection 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
58 | Human cytomegalovirus infection 7 genes, 5 drugs (DrugBank) and 60 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
59 | Human immunodeficiency virus 1 infection 6 genes, 4 drugs (DrugBank) and 59 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
60 | Human papillomavirus infection 2 genes, 3 drugs (DrugBank) and 16 diseases shown |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
61 | Human T-cell leukemia virus 1 infection 6 genes, 4 drugs (DrugBank) and 59 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
62 | Hypertrophic cardiomyopathy (HCM) 9 genes, 4 drugs (DrugBank) and 19 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
63 | IL-17 signaling pathway 2 genes, 3 drugs (DrugBank) and 16 diseases shown |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
64 | Inflammatory bowel disease (IBD) 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
65 | Inflammatory mediator regulation of TRP channels 2 genes, 2 drugs (DrugBank) and 7 diseases shown |
1件: NGF |
D09387 |
Tanezumab |
2件: 226, 298 |
1件: TRPV1 |
D00250 |
Capsaicin |
6件: 2, 6, 19, 86, 113, 226 |
66 | Influenza A 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
67 | Insulin resistance 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
68 | Insulin secretion 6 genes, 2 drugs (DrugBank) and 13 diseases shown |
5件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM3 |
D08441 |
Propiverine |
1件: 226 |
1件: SNAP25 |
D00783 |
Botulinum toxin type A |
13件: 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
69 | Kaposi sarcoma-associated herpesvirus infection 6 genes, 3 drugs (DrugBank) and 56 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
70 | Legionellosis 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
71 | Leishmaniasis 2 genes, 3 drugs (DrugBank) and 16 diseases shown |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
72 | Long-term potentiation 6 genes, 3 drugs (DrugBank) and 55 diseases shown |
1件: CACNA1C |
D08441 |
Propiverine |
1件: 226 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
73 | Malaria 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
74 | MAPK signaling pathway 15 genes, 7 drugs (DrugBank) and 62 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
1件: NGF |
D09387 |
Tanezumab |
2件: 226, 298 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
75 | Metabolic pathways 5 genes, 4 drugs (DrugBank) and 47 diseases shown |
2件: IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
1件: PDE5A |
D02229 |
Sildenafil |
16件: 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
D08514 |
2件: PTGS1, PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
76 | MicroRNAs in cancer 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
77 | Morphine addiction 1 gene, 3 drugs (DrugBank) and 9 diseases shown |
1件: OPRM1 |
D01340 |
Naloxone |
2件: 6, 226 |
D08249 |
D03783 |
Oxycodone |
7件: 6, 13, 46, 70, 226, 231, 298 |
D05312 |
D05462 |
D01355 |
Tramadol |
5件: 46, 70, 78, 226, 271 |
D08623 |
78 | mTOR signaling pathway 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
79 | Natural killer cell mediated cytotoxicity 6 genes, 4 drugs (DrugBank) and 59 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
80 | Necroptosis 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
81 | Neuroactive ligand-receptor interaction 21 genes, 12 drugs (DrugBank) and 41 diseases shown |
9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
3件: ADRA2A, ADRA2B, ADRA2C |
D00514 |
Dexmedetomidine |
11件: 2, 4, 6, 21, 34, 70, 113, 212, 215, 226, 280 |
D01205 |
1件: ADRB1 |
D00601 |
Metoprolol |
7件: 17, 57, 58, 66, 113, 193, 226 |
D02358 |
D05011 |
1件: ADRB3 |
D09535 |
Mirabegron |
3件: 6, 13, 226 |
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D08441 |
Propiverine |
1件: 226 |
1件: NR3C1 |
D00385 |
Triamcinolone |
18件: 6, 10, 13, 35, 40, 41, 42, 43, 44, 45, 46, 56, 70, 90, 96, 97, 226, 298 |
D00983 |
D00984 |
D00985 |
D06216 |
3件: OPRD1, OPRK1, OPRM1 |
D01340 |
Naloxone |
2件: 6, 226 |
D08249 |
D03783 |
Oxycodone |
7件: 6, 13, 46, 70, 226, 231, 298 |
D05312 |
D05462 |
1件: OPRM1 |
D01355 |
Tramadol |
5件: 46, 70, 78, 226, 271 |
D08623 |
1件: OXTR |
D00089 |
Oxytocin |
4件: 127, 193, 206, 226 |
1件: P2RX3 |
D11349 |
Gefapixant |
2件: 85, 226 |
1件: TRPV1 |
D00250 |
Capsaicin |
6件: 2, 6, 19, 86, 113, 226 |
82 | Neurotrophin signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: NGF |
D09387 |
Tanezumab |
2件: 226, 298 |
83 | NF-kappa B signaling pathway 2 genes, 3 drugs (DrugBank) and 16 diseases shown |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
84 | NOD-like receptor signaling pathway 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
85 | Non-alcoholic fatty liver disease (NAFLD) 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
86 | Oocyte meiosis 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
87 | Osteoclast differentiation 6 genes, 4 drugs (DrugBank) and 59 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
88 | Ovarian steroidogenesis 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
89 | Oxytocin signaling pathway 15 genes, 6 drugs (DrugBank) and 61 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
1件: OXTR |
D00089 |
Oxytocin |
4件: 127, 193, 206, 226 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
90 | Pancreatic secretion 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CHRM3 |
D08441 |
Propiverine |
1件: 226 |
91 | Pathogenic Escherichia coli infection 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
92 | Pathways in cancer 3 genes, 2 drugs (DrugBank) and 6 diseases shown |
2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
93 | PD-L1 expression and PD-1 checkpoint pathway in cancer 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
94 | Pertussis 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
95 | Phospholipase D signaling pathway 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: FCER1A |
D05251 |
Omalizumab |
6件: 53, 65, 98, 162, 226, 299 |
96 | PI3K-Akt signaling pathway 3 genes, 2 drugs (DrugBank) and 2 diseases shown |
2件: CHRM1, CHRM2 |
D08441 |
Propiverine |
1件: 226 |
1件: NGF |
D09387 |
Tanezumab |
2件: 226, 298 |
97 | Platelet activation 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: PTGS1 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
98 | Prolactin signaling pathway 2 genes, 1 drug (DrugBank) and 5 diseases shown |
2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
99 | Proteoglycans in cancer 2 genes, 3 drugs (DrugBank) and 18 diseases shown |
1件: ESR1 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
100 | Purine metabolism 3 genes, 3 drugs (DrugBank) and 46 diseases shown |
2件: IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
1件: PDE5A |
D02229 |
Sildenafil |
16件: 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
D08514 |
101 | Rap1 signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: NGF |
D09387 |
Tanezumab |
2件: 226, 298 |
102 | Ras signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: NGF |
D09387 |
Tanezumab |
2件: 226, 298 |
103 | Regulation of actin cytoskeleton 5 genes, 1 drug (DrugBank) and 1 disease shown |
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D08441 |
Propiverine |
1件: 226 |
104 | Regulation of lipolysis in adipocytes 5 genes, 4 drugs (DrugBank) and 16 diseases shown |
1件: ADRB1 |
D00601 |
Metoprolol |
7件: 17, 57, 58, 66, 113, 193, 226 |
D02358 |
D05011 |
3件: ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
1件: ADRB3 |
D09535 |
Mirabegron |
3件: 6, 13, 226 |
2件: PTGS1, PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
105 | Renin secretion 12 genes, 6 drugs (DrugBank) and 62 diseases shown |
1件: ADRB1 |
D00601 |
Metoprolol |
7件: 17, 57, 58, 66, 113, 193, 226 |
D02358 |
D05011 |
3件: ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
1件: ADRB3 |
D09535 |
Mirabegron |
3件: 6, 13, 226 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
106 | Retrograde endocannabinoid signaling 5 genes, 2 drugs (DrugBank) and 2 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
107 | Rheumatoid arthritis 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
108 | RIG-I-like receptor signaling pathway 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
109 | Salivary secretion 7 genes, 4 drugs (DrugBank) and 15 diseases shown |
6件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
1件: ADRB1 |
D00601 |
Metoprolol |
7件: 17, 57, 58, 66, 113, 193, 226 |
D02358 |
D05011 |
1件: ADRB3 |
D09535 |
Mirabegron |
3件: 6, 13, 226 |
1件: CHRM3 |
D08441 |
Propiverine |
1件: 226 |
110 | Serotonergic synapse 7 genes, 4 drugs (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
2件: PTGS1, PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
1件: SLC6A4 |
D00809 |
Amitriptyline |
3件: 78, 226, 299 |
D07448 |
D00816 |
Nortriptyline |
2件: 6, 226 |
D08288 |
111 | Shigellosis 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
112 | Small cell lung cancer 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
113 | Sphingolipid signaling pathway 3 genes, 5 drugs (DrugBank) and 25 diseases shown |
1件: FCER1A |
D05251 |
Omalizumab |
6件: 53, 65, 98, 162, 226, 299 |
1件: OPRD1 |
D01340 |
Naloxone |
2件: 6, 226 |
D08249 |
D03783 |
Oxycodone |
7件: 6, 13, 46, 70, 226, 231, 298 |
D05312 |
D05462 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
114 | Synaptic vesicle cycle 4 genes, 4 drugs (DrugBank) and 18 diseases shown |
1件: SLC6A1 |
D00332 |
Gabapentin |
7件: 6, 13, 19, 70, 97, 226, 298 |
2件: SLC6A2, SLC6A4 |
D00809 |
Amitriptyline |
3件: 78, 226, 299 |
D07448 |
D00816 |
Nortriptyline |
2件: 6, 226 |
D08288 |
1件: SNAP25 |
D00783 |
Botulinum toxin type A |
13件: 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
115 | Systemic lupus erythematosus 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
116 | T cell receptor signaling pathway 6 genes, 4 drugs (DrugBank) and 59 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
117 | Taste transduction 6 genes, 4 drugs (DrugBank) and 15 diseases shown |
2件: CACNA1C, CHRM3 |
D08441 |
Propiverine |
1件: 226 |
1件: P2RX3 |
D11349 |
Gefapixant |
2件: 85, 226 |
3件: SCN2A, SCN3A, SCN9A |
D01450 |
Bupivacaine |
7件: 46, 53, 70, 96, 168, 226, 298 |
D07552 |
D00358 |
Lidocaine |
10件: 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
D02086 |
D08127 |
118 | TGF-beta signaling pathway 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
119 | Th1 and Th2 cell differentiation 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
120 | Th17 cell differentiation 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
121 | Thermogenesis 1 gene, 2 drugs (DrugBank) and 9 diseases shown |
1件: ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
D09535 |
Mirabegron |
3件: 6, 13, 226 |
122 | Thyroid hormone signaling pathway 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: ESR1 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
123 | Tight junction 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CACNA1D |
D08441 |
Propiverine |
1件: 226 |
124 | TNF signaling pathway 2 genes, 3 drugs (DrugBank) and 16 diseases shown |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
125 | Toll-like receptor signaling pathway 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
126 | Toxoplasmosis 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
127 | Tuberculosis 6 genes, 4 drugs (DrugBank) and 59 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
128 | Type I diabetes mellitus 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
129 | Type II diabetes mellitus 3 genes, 3 drugs (DrugBank) and 15 diseases shown |
2件: CACNA1C, CACNA1D |
D08441 |
Propiverine |
1件: 226 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
130 | Vascular smooth muscle contraction 7 genes, 2 drugs (DrugBank) and 9 diseases shown |
3件: ADRA1A, ADRA1B, ADRA1D |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
D00996 |
D02149 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D08441 |
Propiverine |
1件: 226 |
131 | VEGF signaling pathway 6 genes, 3 drugs (DrugBank) and 56 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PTGS2 |
D00813 |
Ketorolac |
2件: 70, 226 |
D08104 |
132 | Viral protein interaction with cytokine and cytokine receptor 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
133 | Wnt signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
134 | Yersinia infection 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |